Skip to content
ChickenStockChickenStock
ResearchRGEN
Repligen logo

Repligen (RGEN) stock

NASDAQ

$167.79+0.76%(+1.27)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-894.92x

Net loss — not comparable

P/B

5.13x

P/S

13.34x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 10.6% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 30, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

18 SEC filings
  • Douglass Brian RobbCHIEF PRODUCT OFFICER · Oct 6, 2026Grant or award700 shares · $0
    Avg. price $08,685 shares held after
  • Loeillot OlivierChief Executive Officer · Oct 5, 2026Open-market sale5,535 shares · $1.0M
    Avg. price $187.290745,788 shares held after
    Show 2 price lots
    • 4,202 shares × $190$798K
    • 1,333 shares × $178.75$238K
  • Loeillot OlivierChief Executive Officer · Oct 5, 2026Option exercise4,202 shares · $651K
    Avg. price $154.9649,990 shares held after
  • Loeillot OlivierChief Executive Officer · Oct 2, 2026Shares withheld for taxes1,248 shares · $227K
    Avg. price $181.747,121 shares held after
  • Garland Jason KCFO · Sep 25, 2026Shares withheld for taxes421 shares · $80K
    Avg. price $189.6818,408 shares held after
  • Loeillot OlivierChief Executive Officer · Sep 24, 2026Open-market sale12,946 shares · $2.5M
    Avg. price $19048,369 shares held after
    Show 2 price lots
    • 8,404 shares × $190$1.6M
    • 4,542 shares × $190$863K
  • Loeillot OlivierChief Executive Officer · Sep 24, 2026Option exercise12,946 shares · $2.0M
    Avg. price $155.1074
    Show 2 price lots
    • 8,404 shares × $154.96$1.3M
    • 4,542 shares × $155.38$706K
  • Loeillot OlivierChief Executive Officer · Sep 21, 2026Open-market sale5,426 shares · $977K
    Avg. price $18048,369 shares held after
  • Loeillot OlivierChief Executive Officer · Sep 21, 2026Option exercise5,426 shares · $769K
    Avg. price $141.7953,795 shares held after
  • Loeillot OlivierChief Executive Officer · Sep 4, 2026Open-market sale3,035 shares · $504K
    Avg. price $165.948,369 shares held after
  • Loeillot OlivierChief Executive Officer · Sep 3, 2026Shares withheld for taxes2,842 shares · $482K
    Avg. price $169.6151,404 shares held after
  • Hughes ViolettaCHIEF ACCOUNTING OFFICER · Sep 1, 2026Shares withheld for taxes277 shares · $47K
    Avg. price $170.026,331 shares held after
  • Loeillot OlivierChief Executive Officer · Aug 20, 2026Open-market sale5,426 shares · $977K
    Avg. price $18054,246 shares held after
  • Loeillot OlivierChief Executive Officer · Aug 20, 2026Option exercise5,426 shares · $769K
    Avg. price $141.7959,672 shares held after
  • Hughes ViolettaCHIEF ACCOUNTING OFFICER · Mar 5, 2026Grant or award2,466 shares · $0
    Avg. price $06,608 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Repligen (RGEN) stock information

NASDAQ

Repligen (RGEN) is listed on NASDAQ. Its market capitalization is about $10.7B. On trailing-twelve-month earnings the P/E ratio is -894.92, and the P/B ratio is 5.13. Return on equity is -0.6%. These figures are computed in-house from official filings and are reference information only.

Repligen — frequently asked questions

What is the P/E ratio of Repligen (RGEN)?
On a trailing-twelve-month basis, RGEN trades at a P/E ratio of -894.92. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Repligen?
RGEN has a market capitalization of about $10.7B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.